Sunday, the New York Times reported that drug companies, insurers, and pharmacies may “team up” to create effective monopolies. Company executives argue that this would be better for patients and would improve care and outcomes—however, nothing could be further than the truth. These conglomerates would further limit access and drive up costs.

Continue reading on Washington Examiner.